Hide metadata

dc.date.accessioned2022-03-18T17:50:30Z
dc.date.available2022-03-18T17:50:30Z
dc.date.created2021-11-04T14:50:31Z
dc.date.issued2021
dc.identifier.citationChaibi, Aleksander Stavem, Knut Russell, Michael Bjørn . Spinal manipulative therapy for acute neck pain: A systematic review and meta-analysis of randomised controlled trials. Journal of Clinical Medicine. 2021, 10(21)
dc.identifier.urihttp://hdl.handle.net/10852/92586
dc.description.abstract(1) Background: Acute neck pain is common and usually managed by medication and/or manual therapy. General practitioners (GPs) hesitate to refer to manual therapy due to uncertainty about the effectiveness and adverse events (AEs); (2) Method: To review original randomized controlled trials (RCTs) assessing the effect of spinal manipulative therapy (SMT) for acute neck pain. Data extraction was done in duplicate and formulated in tables. Quality and evidence were assessed using the Cochrane Back and Neck (CBN) Risk of Bias tool and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria, respectively; (3) Results: Six studies were included. The overall pooled effect size for neck pain was very large −1.37 (95% CI, −2.41, −0.34), favouring treatments with SMT compared with controls. A single study that showed that SMT was statistically significantly better than medicine (30 mg ketorolac im.) one day post-treatment, ((−2.8 (46%) (95% CI, −2.1, −3.4) vs. −1.7 (30%) (95% CI, −1.1, −2.3), respectively; p = 0.02)). Minor transient AEs reported included increased pain and headache, while no serious AEs were reported; (4) Conclusions: SMT alone or in combination with other modalities was effective for patients with acute neck pain. However, limited quantity and quality, pragmatic design, and high heterogeneity limit our findings.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleSpinal manipulative therapy for acute neck pain: A systematic review and meta-analysis of randomised controlled trials
dc.typeJournal article
dc.creator.authorChaibi, Aleksander
dc.creator.authorStavem, Knut
dc.creator.authorRussell, Michael Bjørn
cristin.unitcode185,52,10,0
cristin.unitnameAvdeling for tverrfaglig helsevitenskap
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1951480
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Clinical Medicine&rft.volume=10&rft.spage=&rft.date=2021
dc.identifier.jtitleJournal of Clinical Medicine
dc.identifier.volume10
dc.identifier.issue21
dc.identifier.pagecount15
dc.identifier.doihttps://doi.org/10.3390/jcm10215011
dc.identifier.urnURN:NBN:no-95166
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2077-0383
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/92586/1/jcm-10-05011.pdf
dc.type.versionPublishedVersion
cristin.articleid5011


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International